Evidence map›Paper›PMID 30048149›Full record

ReviewThe British journal of radiology2018

MIBG (metaiodobenzylguanidine) theranostics in pediatric and adult malignancies.

Archi Agrawal, Venkatesh Rangarajan, Sneha Shah, Ameya Puranik, Nilendu Purandare

Abstract readReview
In one paragraph

Review in The British journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Iodine-131 (Quantitative imaging in medicine and surgery · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Late Onset Malignant Metastatic Transformation of Benign Pheochromocytoma.Journal of community hospital internal medicine perspectives · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Theranostics and Patient-Specific Dosimetry.Seminars in radiation oncology · 2023
    Review
  14. Biological Insight and Recent Advancement in the Treatment of Neuroblastoma.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Archi Agrawal1 Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital , Mumbai , India.
Venkatesh Rangarajan1 Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital , Mumbai , India.
Sneha Shah1 Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital , Mumbai , India.
Ameya Puranik1 Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital , Mumbai , India.
Nilendu Purandare1 Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital , Mumbai , India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metaiodobenzylguanidine, a guanithidine analog, labeled with

Indexed as

3-IodobenzylguanidineRadiopharmaceuticalsTheranostic NanomedicineAdrenal Gland NeoplasmsAdultBiological AvailabilityChildContraindications, ProcedureDrug InteractionsHumansNeoplasm StagingNeuroblastomaOrgan Sparing TreatmentsPrecision MedicineRadioactive TracersRadionuclide Imaging3-IodobenzylguanidineRadioactive TracersRadiopharmaceuticals

Identifiers

PMID30048149
PMCPMC6475939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.